GlassScriptPhysician profile
Kayla Sanders
NPI 1104589035
$1,993.52
in general payments reported to CMS, 2019-2025
15 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.60 · 2022: $795 · 2023: $488 · 2024: $435 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $578.02 | 2021-2024 | |
| Alkermes, INC. | $387.89 | 2022-2025 | Lybalvi, Aristada |
| Janssen Pharmaceuticals, INC | $275.15 | 2022-2024 | Invega Sustenna, Invega Trinza, Spravato |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $181.54 | 2021-2024 | Caplyta |
| Indivior INC. | $154.09 | 2022-2024 | Perseris |
| Teva Pharmaceuticals USA, INC. | $121.24 | 2022-2025 | Uzedy, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $79.83 | 2021-2024 | Abilify Maintena, Rexulti |
| Neurocrine Biosciences, INC. | $76.12 | 2021-2025 | |
| Acadia Pharmaceuticals INC | $39.66 | 2022 | |
| Sunovion Pharmaceuticals INC. | $31.21 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.94 | 2024 | Cobenfy |
| Bausch Health US, LLC | $14.71 | 2022 | |
| Vanda Pharmaceuticals INC. | $13.37 | 2024 | Hetlioz, Fanapt |
| Ironshore Pharmaceuticals INC. | $12.56 | 2022 | |
| Corium, LLC | $12.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.